Characterise nanomedicine particles with precision using NanoSight Pro. Improve stability, targeting, and development outcomes.
Nanomedicine is transforming modern therapeutics by enabling precise control over how drugs are delivered, distributed, and released within the body. By leveraging nanoscale materials such as polymer nanoparticles, lipid-based carriers, and inorganic nanomaterials, researchers can enhance therapeutic performance beyond the limits of conventional formulations.
These advanced delivery systems play a critical role in improving drug stability, targeting specific tissues or cells, and controlling pharmacokinetics. As nanomedicine continues to expand across areas such as oncology, vaccines, and gene therapy, the need for accurate and reproducible characterisation becomes increasingly important.
However, nanomedicine systems are inherently complex. They often consist of heterogeneous particle populations where small differences in size, concentration, or structure can significantly influence biodistribution, cellular uptake, and overall therapeutic efficacy.
This creates a fundamental analytical challenge. To ensure consistency and performance, scientists must be able to detect subtle variations within nanoparticle populations and understand how these systems behave under real-world conditions.
With NanoSight Pro you can:
✔ Detect nanoscale changes that impact therapeutic performance early
✔ Gain particle-level insight into complex, heterogeneous systems
✔ Generate reproducible data to support confident development decisions
In a field where precision defines success, having the right analytical partner is no longer optional. NanoSight Pro brings clarity to complexity and gives you confidence to move forward with data you can trust. If you want to accelerate development while maintaining control over every critical variable, NanoSight Pro does more than support your workflow. It strengthens it. This is the kind of insight that helps turn promising nanomedicine into viable, scalable therapeutics.
Works with OmniTrust: Malvern Panalytical's compliance solution for the regulated environment
Nanomedicine platforms offer significant advantages, but they also introduce hidden risks that can compromise therapeutic performance if left undetected. These risks often emerge from subtle changes in nanoparticle populations that are not visible using conventional analytical approaches.
These risks are difficult to detect because they originate at the nanoscale, where small changes can have disproportionate effects. Subtle aggregation, inconsistent particle concentrations, and hidden sub-populations can quietly derail performance. Traditional techniques often miss these issues, leaving you exposed to late-stage surprises.
NanoSight Pro changes that. By revealing what conventional techniques miss, it helps you stay ahead of instability, variability, and inconsistency before they become costly problems. If your goal is to reduce risk and make smarter decisions earlier, NanoSight Pro gives you the visibility needed to move forward with confidence.
Many nanomedicine programmes encounter challenges during later stages of development, particularly during scale-up, storage, or clinical translation. These failures are often driven by subtle nanoscale changes that were not identified early in development.
Small shifts in particle size, distribution, or concentration can alter pharmacokinetics, reduce targeting efficiency, or trigger instability.
Late-stage failures are rarely random. They are usually the result of small issues that were not detected early enough. As your formulation scales or faces real-world conditions, these hidden inconsistencies become amplified.
NanoSight Pro is designed to prevent this.
By enabling real-time visualisation and precise measurement of individual particles, it allows you to identify and address problems at the earliest stages. This means fewer surprises, smoother scale-up, and a much stronger chance of success when it matters most.
Aggregation and instability are among the most common causes of reduced performance in nanomedicine systems. Even small levels of aggregation can impact biodistribution, reduce efficacy, and compromise safety.
NanoSight Pro enables direct observation of particle populations, allowing scientists to identify early signs of instability before they impact downstream outcomes. By tracking individual particles, subtle changes can be detected with greater sensitivity and clarity.
With NanoSight Pro, you can:
✔ Identify emerging aggregates before they affect performance
✔ Monitor stability under different formulation and storage conditions
✔ Understand how environmental factors influence nanoparticle behaviour
When it comes to aggregation and instability, early detection makes a critical difference. NanoSight Pro provides that early visibility, allowing you to act before performance is affected.
It is not only about identifying issues, but also about maintaining control over your formulation. For researchers who need to protect product integrity, NanoSight Pro becomes an essential tool for staying ahead of potential challenges.
Effective nanomedicine development requires precise control over formulation parameters. Particle size distribution and concentration directly influence dosing, targeting, and therapeutic exposure.
NanoSight Pro provides high-resolution insight into these parameters, supporting optimisation of formulations to achieve consistent and reproducible performance. This enables more efficient development and reduces the risk of variability.
With NanoSight Pro, you can:
✔ Measure particle concentration by size with high precision
✔ Refine formulations to improve targeting and biodistribution
✔ Ensure consistency across batches and manufacturing processes
Consistency is what transforms a good formulation into a reliable one. NanoSight Pro provides the detailed insight needed to refine key parameters and achieve predictable, repeatable results.
If you are aiming to streamline development while improving performance, NanoSight Pro supports better decision-making at every stage and helps ensure dependable outcomes.
Nanomedicine systems are rarely uniform. They often contain multiple sub-populations of particles with distinct characteristics and behaviours. Understanding this heterogeneity is critical for predicting performance and ensuring reliability.
NanoSight Pro allows researchers to distinguish between different particle populations and analyse them individually. This provides a more complete picture of the system and reveals insights that are not accessible through ensemble techniques.
With NanoSight Pro, you can:
✔ Differentiate co-existing nanoparticle sub-populations
✔ Detect low-abundance particles that may impact outcomes
✔ Build a deeper understanding of system behaviour in solution
Complex systems require deeper understanding, and NanoSight Pro delivers exactly that. By uncovering the differences within heterogeneous populations, it allows you to see beyond averages and understand what is really happening in your sample.
For researchers working at the forefront of nanomedicine, this level of detail is essential. NanoSight Pro turns complexity into clear, actionable insights.
NanoSight Pro provides the level of analytical detail required to fully understand and control nanomedicine systems. By enabling direct, particle-by-particle analysis, it delivers a more accurate and complete view of nanoparticle populations.
This supports better decision-making across the development lifecycle, from early formulation through to scale-up and regulatory submission. With improved insight comes greater confidence in performance, stability, and reproducibility.
✔ Nanoparticle tracking analysis for direct particle visualisation
✔ High-resolution particle size and concentration measurement
✔ Detection of aggregation and instability at an early stage
✔ Identification of heterogeneous and low-abundance populations
✔ Real-time monitoring of nanoparticle behaviour in suspension
✔ Improved formulation optimisation and process control
✔ Enhanced reproducibility across development and manufacturing
✔ Reduced risk of late-stage failure
✔ Stronger data to support regulatory requirements
✔ Faster and more efficient development timelines
Success in nanomedicine depends on confidence in your data, your formulation, and your outcomes. NanoSight Pro brings these elements together in a way few technologies can.
It is perfect for teams that want to move faster, reduce risk, and build a solid case for regulatory approval. If you are serious about advancing nanomedicine, NanoSight Pro helps you stay ahead by enabling you to see, measure, and understand nanoparticles at the level that truly matters for achieving precise and consistent results.
Analyse ADC heterogeneity and stability with NanoSight Pro. Detect aggregation early and optimise conjugation with particle-level insight.
Detect subtle particle differences in biosimilars with NanoSight Pro. Strengthen comparability, reduce risk, and accelerate regulatory approval.
Characterise extracellular vesicles in cell therapy. Gain nanoscale insight into cell health, potency, and consistency with NanoSight Pro.
Analyse extracellular vesicles with precision using NanoSight Pro. Detect heterogeneity, quantify particles, and de-risk exosome development. Gain reproducible insight into vesicle behaviour in solution.
Characterise viral vectors with precision using NanoSight Pro. Measure size, concentration, and aggregation to support gene therapy development.
Characterize lipid nanoparticles with precision using NanoSight Pro to optimise delivery, stability, and performance in biopharma development.
Detect protein aggregation early with NanoSight Pro. Gain particle-level insight to improve stability, reduce risk, and accelerate biologics development.
Detect mAb aggregation and particle heterogeneity early. Optimise stability and reduce risk with NanoSight Pro
Characterise nanomedicine particles with precision using NanoSight Pro. Improve stability, targeting, and development outcomes.
Measure, optimise, and control oncolytic viruses with particle-level insight to reduce risk and accelerate advanced therapy development.
Discover how NanoSight Pro supports Quality Control and Quality Assurance by delivering reliable, reproducible data for regulatory compliant biologics and pharmaceutical development and manufacturing.
Gain reproducible insight into particle and molecular behaviour in vaccine systems. Detect instability, optimise formulations and accelerate vaccine development with Zetasizer.